中国P站

Multiplex polymerase chain reaction (PCR) panels are advanced molecular diagnostic tools that allow simultaneous detection of multiple pathogens or genetic targets in a single test. By amplifying several nucleic acid sequences at once, multiplex PCR significantly reduces the time, cost, and complexity associated with traditional single-target assays. These panels have transformed clinical microbiology, infectious disease diagnostics, and genetic testing, enabling rapid, accurate, and comprehensive identification of causative agents. In an era of emerging infections, antimicrobial resistance, and precision medicine, multiplex PCR panels are becoming indispensable for timely diagnosis and treatment decisions [1, 2].

Discussion

Multiplex PCR panels operate on the principle of simultaneous amplification using multiple primer sets in a single reaction. Each primer is specific to a target gene, allowing the detection of various pathogens—bacterial, viral, fungal, or parasitic—within the same sample. This approach is particularly valuable in clinical settings where rapid diagnosis is critical, such as bloodstream infections, respiratory infections, gastrointestinal infections, and sexually transmitted infections. For example, respiratory multiplex PCR panels can detect influenza, respiratory syncytial virus, adenovirus, and SARS-CoV-2 simultaneously, facilitating prompt isolation and treatment measures [3-6].

The advantages of multiplex PCR panels extend beyond speed and efficiency. They increase diagnostic sensitivity and specificity by reducing false negatives and improving pathogen detection, even in samples with low microbial load. Additionally, panels that include antimicrobial resistance genes, such as those for carbapenemases or methicillin resistance, provide essential information for guiding therapy. This is particularly crucial in settings with high rates of multidrug-resistant organisms, where early identification can improve patient outcomes and limit the spread of resistant pathogens [7, 8].

Multiplex PCR panels also streamline workflow in laboratories. Traditional culture-based methods require prolonged incubation periods, while single-target PCR tests necessitate multiple assays, increasing labor and turnaround time. Multiplex PCR consolidates testing into a single reaction, conserving resources and enabling faster reporting. Furthermore, automated platforms integrated with multiplex panels allow high-throughput processing, which is invaluable during outbreaks or pandemics [9, 10].

Despite their benefits, multiplex PCR panels have limitations. They may be cost-prohibitive for resource-limited settings and can only detect pre-specified targets, potentially missing novel or unexpected pathogens.

Conclusion

Multiplex PCR panels represent a major advancement in diagnostic medicine, offering rapid, accurate, and comprehensive detection of multiple pathogens in a single assay. By improving diagnostic efficiency, enabling detection of resistance genes, and facilitating timely therapeutic decisions, these panels enhance patient care and support public health initiatives. While limitations exist, ongoing innovations and integration into clinical practice continue to expand their utility. As infectious disease challenges grow increasingly complex, multiplex PCR panels remain a pivotal tool in modern diagnostics, shaping the future of precision medicine and global health preparedness.

References

1. Geremia A, Biancheri P, Allan P, Corazza GR, Sabatino A (2014) . Autoimmune Rev 13: 3–10.

   , ,

2. Boltin D, Perets TT, Vilkin A, Niv Y (2013) . J Clin Gastroenterol 47: 106–111.

   , ,

3. Johansson ME, Stovall H, Hansson GC (2013) . Nat Rev Gastroenterol Hepatol 10: 352–361.

   , ,

4. Chassaing B, Darfeuille-Michaud A (2011) . Gastroenterology 140: 1720–1728.

   , ,

5. Bergstrom KS, Kissoon-Singh V, Gibson DL, Montero M, Sham, Huang T et al. (2010) . PLoS Pathog 6: 148-150.

   , ,

6. Johansson ME, Gustafsson JK, Holmen-Larsson J, Jabbar KS, Xia L, et al. (2014) . Gut 63: 281–291.

   , ,

7. Schwerbrock NM, Makkink MK, Buller HA, Einerhand AW, Sartor RB et al. (2004) . Inflamm Bowel Dis 10: 811–823.

   , ,

8. Atuma C, Strugala V, Allen A, Holm L (2001) . Am J Physiol Gastrointest Liver Physiol 280: 922–929.

   , ,

9. Ermund A, Schütte A, Johansson ME, Gustafsson JK, Hansson GC, et al. (2013) Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer’s patches. Am J Physiol Gastrointest Liver Physiol 305: 341–347.

   Indexed at, ,

10. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, et al. (2011) . Science 334: 255–258.

    , ,